Cardiovascular safety in type 2 diabetes with sulfonylureas as second-line drugs: a nation-wide population-based comparative safety study (original) (raw)

Additional Information:

This work was supported by Health Data Research UK which receives its funding from HDR UK Ltd (HDR-5012) funded by the UK Medical Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council, Department of Health and Social Care (England), Chief Scientist Office of the Scottish Government Health and Social Care Directorates, Health and Social Care Research and Development Division (Welsh Government), Public Health Agency (Northern Ireland), British Heart Foundation (BHF), and the Wellcome Trust.

Authors:

Wang, H., Cordiner, R. L.M., Huang, Y., Donnelly, L., Hapca, S., Collier, A., McKnight, J., Kennon, B., Gibb, F., McKeigue, P., Wild, S. H., Colhoun, H., Chalmers, J., Petrie, J., Sattar, N., MacDonald, T., McCrimmon, R. J., Morales, D. R., Pearson, E. R., Blackbourn, L., Cunningham, S., Gibb, F., Leese, G., Lindsay, R., McAllister, D., McGurnaghan, S., and Philip, S.

Publisher:

American Diabetes Association